다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
The New England journal of medicine, v.352 no.12, 2005년, pp.1223 - 1236
Ehrmann, David A.
초록이 없습니다.
Am J Obstet Gynecol Stein IF 181 29 1935 10.1016/S0002-9378(15)30642-6
Franks, Stephen. Polycystic Ovary Syndrome. The New England journal of medicine, vol.333, no.13, 853-861.
Revised 2003 consensus on diagnostic criteria and long‐term health risks related to polycystic ovary syndrome (PCOS). Human reproduction, vol.19, no.1, 41-47.
Adams, J, Polson, D W, Franks, S. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism.. British medical journal, vol.293, no.6543, 355-359.
Ehrmann, David A., Rosenfield, Robert L., Barnes, Randall B., Brigell, Deborah F., Sheikh, Zubie. Detection of Functional Ovarian Hyperandrogenism in Women with Androgen Excess. The New England journal of medicine, vol.327, no.3, 157-162.
Polson, D.W., Wadsworth, J., Adams, J., Franks, S.. POLYCYSTIC OVARIES-A COMMON FINDING IN NORMAL WOMEN. The Lancet, vol.331, no.8590, 870-872.
Michelmore, K. F., Balen, A. H., Dunger, D. B., Vessey, M. P.. Polycystic ovaries and associated clinical and biochemical features in young women. Clinical endocrinology, vol.51, no.6, 779-786.
WALDSTREICHER, JOANNE, SANTORO, NANETTE F., HALL, JANET E., FILICORI, MARCO, CROWLEY JR., WILLIAM F.. Hyperfunction of the Hypothalamic-Pituitary Axis in Women with Polycystic Ovarian Disease: Indirect Evidence for Partial Gonadotroph Desensitization*. The Journal of clinical endocrinology & metabolism, vol.66, no.1, 165-172.
Ehrmann, D A, Barnes, R B, Rosenfield, R L, Cavaghan, M K, Imperial, J. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.. Diabetes care, vol.22, no.1, 141-146.
Franks, S.. Adult polycystic ovary syndrome begins in childhood. Best practice & research. Clinical endocrinology & metabolism, vol.16, no.2, 263-272.
Ibáñez, Lourdes, Valls, Carme, Potau, Neus, Marcos, Maria Victoria, De Zegher, Francis. Polycystic ovary syndrome after precocious pubarche: ontogeny of the low‐birthweight effect. Clinical endocrinology, vol.55, no.5, 667-672.
10.1210/jc.85.3.1206
Eisner, Joel R., Dumesic, Daniel A., Kemnitz, Joseph W., Colman, Ricki J., Abbott, David H.. Increased Adiposity in Female Rhesus Monkeys Exposed to Androgen Excess During Early Gestation. Obesity research, vol.11, no.2, 279-286.
Eisner, Joel R., Barnett, Melissa A., Dumesic, Daniel A., Abbott, David H.. Ovarian hyperandrogenism in adult female rhesus monkeys exposed to prenatal androgen excess. Fertility and sterility, vol.77, no.1, 167-172.
Abbott, DH, Dumesic, DA, Franks, S. Developmental origin of polycystic ovary syndrome - a hypothesis. The Journal of endocrinology, vol.174, no.1, 1-5.
Nelson, V L, Legro, R S, Strauss, J F, McAllister, J M. Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries.. Molecular endocrinology, vol.13, no.6, 946-957.
10.1210/jc.86.12.5925
Haisenleder, D J, Dalkin, A C, Ortolano, G A, Marshall, J C, Shupnik, M A. A pulsatile gonadotropin-releasing hormone stimulus is required to increase transcription of the gonadotropin subunit genes: evidence for differential regulation of transcription by pulse frequency in vivo.. Endocrinology, vol.128, no.1, 509-517.
10.1210/jc.85.11.4047
10.1210/jc.83.9.3078
10.1210/jc.84.11.4006
10.1210/jc.85.7.2434
Kauffman, Robert P., Baker, Vicki M., DiMarino, Pamela, Gimpel, Terry, Castracane, V.Daniel. Polycystic ovarian syndrome and insulin resistance in white and Mexican American women: A comparison of two distinct populations. American journal of obstetrics and gynecology, vol.187, no.5, 1362-1369.
Williamson, Karen, Gunn, Alistair J, Johnson, Neil, Milsom, Stella R. The impact of ethnicity on the presentation of polycystic ovarian syndrome. The Australian & New Zealand journal of obstetrics & gynaecology, vol.41, no.2, 202-206.
J Pediatr Endocrinol Metab Azziz R 1303 13 2000
Urbanek, Margrit, Legro, Richard S., Driscoll, Deborah A., Azziz, Ricardo, Ehrmann, David A., Norman, Robert J., Strauss III, Jerome F., Spielman, Richard S., Dunaif, Andrea. Thirty-seven candidate genes for polycystic ovary syndrome: Strongest evidence for linkage is with follistatin. Proceedings of the National Academy of Sciences of the United States of America, vol.96, no.15, 8573-8578.
Ehrmann, D A, Sturis, J, Byrne, M M, Karrison, T, Rosenfield, R L, Polonsky, K S. Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus.. The Journal of clinical investigation, vol.96, no.1, 520-527.
Legro, Richard S., Driscoll, Deborah, Strauss III, Jerome F., Fox, Janis, Dunaif, Andrea. Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proceedings of the National Academy of Sciences of the United States of America, vol.95, no.25, 14956-14960.
Kahsar-Miller, Melissa D, Nixon, Christa, Boots, Larry R, Go, Rodney C, Azziz, Ricardo. Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS. Fertility and sterility, vol.75, no.1, 53-58.
Urbanek, Margrit, Spielman, Richard S.. Genetic analysis of candidate genes for the polycystic ovary syndrome. Current opinion in endocrinology & diabetes, vol.9, no.6, 492-501.
Wood, Jennifer R., Nelson, Velen L., Ho, Clement, Jansen, Erik, Wang, Clare Y., Urbanek, Margrit, McAllister, Jan M., Mosselman, Sietse, Strauss III, Jerome F.. The Molecular Phenotype of Polycystic Ovary Syndrome (PCOS) Theca Cells and New Candidate PCOS Genes Defined by Microarray Analysis. The Journal of biological chemistry, vol.278, no.29, 26380-26390.
Draper, Nicole, Walker, Elizabeth A, Bujalska, Iwona J, Tomlinson, Jeremy W, Chalder, Susan M, Arlt, Wiebke, Lavery, Gareth G, Bedendo, Oliver, Ray, David W, Laing, Ian, Malunowicz, Ewa, White, Perrin C, Hewison, Martin, Mason, Philip J, Connell, John M, Shackleton, Cedric H L, Stewart, Paul M. Mutations in the genes encoding 11β-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency. Nature genetics, vol.34, no.4, 434-439.
10.1210/jc.86.1.446
Waterworth, Dawn M, Bennett, Simon T, Gharani, Neda, McCarthy, Mark I, Hague, Stephen, Batty, Sari, Conway, Gerard S, White, Davinia, Todd, John A, Franks, Stephen, Williamson, Robert. Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome. The Lancet, vol.349, no.9057, 986-990.
VANKOVÁ, MARKÉTA, VRBÍKOVÁ, JANA, HILL, MARTIN, CINEK, ONDREJ, BENDLOVÁ, BELA. Association of Insulin Gene VNTR Polymorphism with Polycystic Ovary Syndrome. Annals of the New York Academy of Sciences, vol.967, no.1, 558-565.
Michelmore, Katherine, Ong, Ken, Mason, Sam, Bennett, Simon, Perry, Leslie, Vessey, Martin, Balen, Adam, Dunger, David. Clinical features in women with polycystic ovaries: relationships to insulin sensitivity, insulin gene VNTR and birth weight. Clinical endocrinology, vol.55, no.4, 439-446.
Ehrmann, David A., Tang, Xu, Yoshiuchi, Issei, Cox, Nancy J., Bell, Graeme I.. Relationship of Insulin Receptor Substrate-1 and -2 Genotypes to Phenotypic Features of Polycystic Ovary Syndrome. The Journal of clinical endocrinology & metabolism, vol.87, no.9, 4297-4300.
El Mkadem, Samira Ait, Lautier, Corinne, Macari, Françoise, Molinari, Nicolas, Lefèbvre, Patrick, Renard, Eric, Gris, Jean Christophe, Cros, Gérard, Daurès, Jean Pierre, Bringer, Jacques, White, Morris F., Grigorescu, Florin. Role of Allelic Variants Gly972Arg of IRS-1 and Gly1057Asp of IRS-2 in Moderate-to-Severe Insulin Resistance of Women With Polycystic Ovary Syndrome. Diabetes, vol.50, no.9, 2164-2168.
10.1210/jc.87.4.1669
Gonzalez, Alejandro, Abril, Eduardo, Roca, Alfredo, Aragón, Maria José, Figueroa, Maria José, Velarde, Pilar, Ruiz, Rocío, Fayez, Omar, Galán, José Jorge, Herreros, José Antonio, Real, Luis Miguel, Ruiz, Agustín. Specific CAPN10 Gene Haplotypes Influence the Clinical Profile of Polycystic Ovary Patients. The Journal of clinical endocrinology & metabolism, vol.88, no.11, 5529-5536.
Orio Jr., Francesco, Matarese, Giuseppe, Di Biase, Sebastiano, Palomba, Stefano, Labella, Donato, Sanna, Veronica, Savastano, Silvia, Zullo, Fulvio, Colao, Annamaria, Lombardi, Gaetano. Exon 6 and 2 Peroxisome Proliferator-Activated Receptor-γ Polymorphisms in Polycystic Ovary Syndrome. The Journal of clinical endocrinology & metabolism, vol.88, no.12, 5887-5892.
Korhonen, S., Heinonen, S., Hiltunen, M., Helisalmi, S., Hippeläinen, M., Koivunen, R., Tapanainen, J.S., Laakso, M.. Polymorphism in the peroxisome proliferator‐activated receptor‐γ gene in women with polycystic ovary syndrome. Human reproduction, vol.18, no.3, 540-543.
San Millán, José L., Cortón, Marta, Villuendas, Gemma, Sancho, José, Peral, Belén, Escobar-Morreale, Héctor F.. Association of the Polycystic Ovary Syndrome with Genomic Variants Related to Insulin Resistance, Type 2 Diabetes Mellitus, and Obesity. The Journal of clinical endocrinology & metabolism, vol.89, no.6, 2640-2646.
10.1210/jc.2003-031189
10.1210/jc.85.12.4455
10.1210/jc.87.1.161
10.1210/jc.2002-021553
Xita, Nectaria, Tsatsoulis, Agathocles, Chatzikyriakidou, Anthi, Georgiou, Ioannis. Association of the (TAAAA)n Repeat Polymorphism in the Sex Hormone-Binding Globulin (SHBG) Gene with Polycystic Ovary Syndrome and Relation to SHBG Serum Levels. The Journal of clinical endocrinology & metabolism, vol.88, no.12, 5976-5980.
Carey, A H, Waterworth, D, Patel, K, White, D, Little, J, Novelli, P, Franks, S, Williamson, R. Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17.. Human molecular genetics, vol.3, no.10, 1873-1876.
Franks, Stephen, White, Davinia, Gilling-Smith, Carole, Carey, Adam, Waterworth, Dawn, Williamson, Robert. Hypersecretion of androgens by polycystic ovaries: The role of genetic factors in the regulation of cytochrome P450c17α. Baillière's clinical endocrinology and metabolism, vol.10, no.2, 193-203.
J Endocrinol Invest Liovic M 189 20 1997 10.1007/BF03346901
Techatraisak, K., Conway, G. S., Rumsby, G.. Frequency of a polymorphism in the regulatory region of the 17α‐hydroxylase‐17,20‐lyase (CYP17) gene in hyperandrogenic states. Clinical endocrinology, vol.46, no.2, 131-134.
Diamanti-Kandarakis, Evanthia, Bartzis, Michael I, Zapanti, Evangelia D, Spina, Giovanna G, Filandra, Fanny A, Tsianateli, Thomais C, Bergiele, Angeliki T, Kouli, Chryssa R. Polymorphism T→C (−34 bp) of gene CYP17 promoter in Greek patients with polycystic ovary syndrome. Fertility and sterility, vol.71, no.3, 431-435.
Gharani, N., Waterworth, D. M., Batty, S., White, D., Gilling-Smith, C., Conway, G. S., McCarthy, M., Franks, S., Williamson, R.. Association of the Steroid Synthesis Gene Cyp11a with Polycystic Ovary Syndrome and Hyperandrogenism. Human molecular genetics, vol.6, no.3, 397-402.
Diamanti-Kandarakis, Evanthia, Bartzis, Michael I, Bergiele, Angeliki T, Tsianateli, Thomais C, Kouli, Chryssa R. Microsatellite polymorphism (tttta)n at −528 base pairs of gene CYP11α influences hyperandrogenemia in patients with polycystic ovary syndrome. Fertility and sterility, vol.73, no.4, 735-741.
10.1210/jc.2003-031640
Rold??n, Bel??n, San Mill??n, Jos?? L, Escobar-Morreale, H??ctor F. Genetic Basis of Metabolic Abnormalities in Polycystic Ovary Syndrome : Implications for Therapy. American journal of pharmacogenomics : genomics-related research in drug development and clinical practice, vol.4, no.2, 93-107.
J Endocrinol Invest Carmina E 1151 26 2003 10.1007/BF03345266
Glueck, C.J, Papanna, Ranganath, Wang, Ping, Goldenberg, Naila, Sieve-Smith, Luann. Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome. Metabolism : clinical and experimental, vol.52, no.7, 908-915.
Circulation 3143 106 2002 10.1161/circ.106.25.3143
Sam, Susan, Dunaif, Andrea. Polycystic ovary syndrome: Syndrome XX?. Trends in endocrinology and metabolism : TEM, vol.14, no.8, 365-370.
10.1210/jc.86.4.1626
FRANKS, STEPHEN. POLYCYSTIC OVARY SYNDROME: A CHANGING PERSPECTIVE. Clinical endocrinology, vol.31, no.1, 87-120.
CONWAY, G. S., HONOUR, J. W., JACOBS, H. S.. HETEROGENEITY OF THE POLYCYSTIC OVARY SYNDROME: CLINICAL, ENDOCRINE AND ULTRASOUND FEATURES IN 556 PATIENTS. Clinical endocrinology, vol.30, no.4, 459-470.
Carmina, Enrico, Legro, Richard S., Stamets, Kelly, Lowell, Jennifer, Lobo, Rogerio A.. Difference in body weight between American and Italian women with polycystic ovary syndrome: influence of the diet. Human reproduction, vol.18, no.11, 2289-2293.
Mokdad, Ali H., Ford, Earl S., Bowman, Barbara A., Dietz, William H., Vinicor, Frank, Bales, Virginia S., Marks, James S.. Prevalence of Obesity, Diabetes, and Obesity-Related Health Risk Factors, 2001. JAMA : the journal of the American Medical Association, vol.289, no.1, 76-.
10.1210/jc.84.1.165
N J Med Krosnick A 31 97 2000
Norman, Robert J., Masters, Lisa, Milner, Clyde R., Wang, Jim X., Davies, Michael J.. Gynaecology. Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome. Human reproduction, vol.16, no.9, 1995-1998.
Dunaif, Andrea, Segal, Karen R, Futterweit, Walter, Dobrjansky, Areta. Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome. Diabetes, vol.38, no.9, 1165-1174.
10.1210/er.18.6.774
Am J Physiol Endocrinol Metab Dunaif A E392 281 2001 10.1152/ajpendo.2001.281.2.E392
10.2337/diabetes.42.11.1663
Flier, Jeffrey S., Underhill, Lisa H., Polonsky, Kenneth S., Sturis, Jeppe, Bell, Graeme I.. Non-Insulin-Dependent Diabetes Mellitus - A Genetically Programmed Failure of the Beta Cell to Compensate for Insulin Resistance. The New England journal of medicine, vol.334, no.12, 777-783.
10.1210/jc.76.5.1241
Ehrmann, D. A., Breda, E., Cavaghan, M. K., Bajramovic, S., Imperial, J., Toffolo, G., Cobelli, C., Polonsky, K. S.. Insulin secretory responses to rising and falling glucose concentrations are delayed in subjects with impaired glucose tolerance. Diabetologia, vol.45, no.4, 509-517.
Ehrmann, David A., Breda, Elena, Corcoran, Matthew C., Cavaghan, Melissa K., Imperial, Jacqueline, Toffolo, Gianna, Cobelli, Claudio, Polonsky, Kenneth S.. Impaired β-cell compensation to dexamethasone-induced hyperglycemia in women with polycystic ovary syndrome. American journal of physiology, Endocrinology and metabolism, vol.287, no.2, E241-E246.
10.1210/jc.81.3.942
Kousta, Eleni, Cela, Ester, Lawrence, Natasha, Penny, Anna, Millauer, Barbara, White, Davinia, Wilson, Helen, Robinson, Stephen, Johnston, Desmond, McCarthy, Mark, Franks, Stephen. The prevalence of polycystic ovaries in women with a history of gestational diabetes. Clinical endocrinology, vol.53, no.4, 501-507.
10.1210/jc.75.2.508
Dahlgren, E., Janson, P. O., Johansson, S., Lapidus, L., Odén, A.. Polycystic ovary syndrome and risk for myocardial infarction: Evaluated from a risk factor model based on a prospective population study of women. Acta obstetricia et gynecologica Scandinavica : AOGS, vol.71, no.8, 599-604.
Fertil Steril Dahlgren E 505 57 1992 10.1016/S0015-0282(16)54892-4
10.1210/jc.87.2.742
Circulation Paradisi G 1410 103 2001 10.1161/01.CIR.103.10.1410
10.1210/jc.2002-020386
Orio Jr., Francesco, Palomba, Stefano, Cascella, Teresa, De Simone, Biagio, Di Biase, Sebastiano, Russo, Tiziana, Labella, Donato, Zullo, Fulvio, Lombardi, Gaetano, Colao, Annamaria. Early Impairment of Endothelial Structure and Function in Young Normal-Weight Women with Polycystic Ovary Syndrome. The Journal of clinical endocrinology & metabolism, vol.89, no.9, 4588-4593.
10.1210/jc.85.5.1851
10.1210/jc.87.8.3871
Orio Jr., Francesco, Palomba, Stefano, Spinelli, Letizia, Cascella, Teresa, Tauchmanovà, Libuse, Zullo, Fulvio, Lombardi, Gaetano, Colao, Annamaria. The Cardiovascular Risk of Young Women with Polycystic Ovary Syndrome: An Observational, Analytical, Prospective Case-Control Study. The Journal of clinical endocrinology & metabolism, vol.89, no.8, 3696-3701.
10.1210/jc.2003-030334
10.1210/jc.82.7.2108
Fertil Steril Dahlgren E 455 61 1994 10.1016/S0015-0282(16)56575-3
Atiomo, William U, Bates, Susie A, Condon, John E, Shaw, Steve, West, Jonathan H, Prentice, Archibald G. The plasminogen activator system in women with polycystic ovary syndrome. Fertility and sterility, vol.69, no.2, 236-241.
Talbott, Evelyn, Guzick, David, Clerici, Annette, Berga, Sarah, Detre, Katherine, Weimer, Karl, Kuller, Lewis. Coronary Heart Disease Risk Factors in Women With Polycystic Ovary Syndrome. Arteriosclerosis, thrombosis, and vascular biology, vol.15, no.7, 821-826.
Wild, Sarah, Pierpoint, Tracey, Jacobs, Howard, McKeigue, Paul. Long-term consequences of polycystic ovary syndrome: Results of a 31 year follow-up study. Human fertility : journal of the British Fertility Society, vol.3, no.2, 101-105.
Minerva Ginecol Talbott EO 27 56 2004
Legro, Richard S.. Polycystic Ovary Syndrome and Cardiovascular Disease: A Premature Association?. Endocrine reviews, vol.24, no.3, 302-312.
10.1210/jc.86.2.517
10.1210/jc.86.3.1175
Gopal, Mira, Duntley, Stephen, Uhles, Matt, Attarian, Hrayr. The role of obesity in the increased prevalence of obstructive sleep apnea syndrome in patients with polycystic ovarian syndrome. Sleep medicine, vol.3, no.5, 401-404.
Hardiman, Paul, Pillay, Ouma S, Atiomo, William. Polycystic ovary syndrome and endometrial carcinoma. The Lancet, vol.361, no.9371, 1810-1812.
Balen, Adam. Polycystic ovary syndrome and cancer. Human reproduction update, vol.7, no.6, 522-525.
Kuhl, Herbert. Comparative Pharmacology of Newer Progestogens :. Drugs, vol.51, no.2, 188-215.
Krattenmacher, Rolf. Drospirenone: pharmacology and pharmacokinetics of a unique progestogen. Contraception, vol.62, no.1, 29-38.
Guido, M., Romualdi, D., Giuliani, M., Suriano, R., Selvaggi, L., Apa, R., Lanzone, A.. Drospirenone for the Treatment of Hirsute Women with Polycystic Ovary Syndrome: A Clinical, Endocrinological, Metabolic Pilot Study. The Journal of clinical endocrinology & metabolism, vol.89, no.6, 2817-2823.
Diamanti-Kandarakis, Evanthia, Baillargeon, Jean-Patrice, Iuorno, Maria J., Jakubowicz, Daniela J., Nestler, John E.. A Modern Medical Quandary: Polycystic Ovary Syndrome, Insulin Resistance, and Oral Contraceptive Pills. The Journal of clinical endocrinology & metabolism, vol.88, no.5, 1927-1932.
GOLLAND, I. M., ELSTEIN, M. E.. Results of an Open One‐Year Study with Diane‐35 in Women with Polycystic Ovarian Syndrome. Annals of the New York Academy of Sciences, vol.687, no.1, 263-271.
Spritzer, Poli Mara, Lisboa, Karen O., Mattiello, Simone, Lhullier, Francisco. Spironolactone as a single agent for long-term therapy of hirsute patients. Clinical endocrinology, vol.52, no.5, 587-594.
Müderris, İ. İ., Bayram, F., Güven, M.. Treatment of hirsutism with lowest-dose flutamide (62.5 mg/day). Gynecological endocrinology : the official journal of the international society of gynecological endocrinology, vol.14, no.1, 38-41.
10.1210/jc.85.1.89
Gambineri, Alessandra, Pelusi, Carla, Genghini, Silvia, Morselli-Labate, Antonio Maria, Cacciari, Mauro, Pagotto, Uberto, Pasquali, Renato. Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome. Clinical endocrinology, vol.60, no.2, 241-249.
10.1210/jc.83.7.2317
10.1210/jc.84.3.946
Liang, T, Heiss, C E, Ostrove, S, Rasmusson, G H, Cheung, A. Binding of a 4-methyl-4-aza-steroid to 5 alpha-reductase of rat liver and prostate microsomes.. Endocrinology, vol.112, no.4, 1460-1468.
Falsetti, L, Gambera, A, Legrenzi, L, Iacobello, C, Bugari, G. RETRACTED: Comparison of finasteride versus flutamide in the treatment of hirsutism. European journal of endocrinology, vol.141, no.4, 361-367.
Minerva Ginecol Yildiz BO 425 55 2003
Minerva Ginecol Barbieri RL 63 56 2004
Franks, Stephen. Assessment and management of anovulatory infertility in polycystic ovary syndrome. Endocrinology and metabolism clinics of North America, vol.32, no.3, 639-651.
Nestler, John E., Stovall, Dale, Akhter, Nausheen, Iuorno, Maria J., Jakubowicz, Daniela J.. Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome. Fertility and sterility, vol.77, no.2, 209-215.
10.1210/jc.84.4.1470
Hoeger, Kathleen M, Kochman, Lynda, Wixom, Nellie, Craig, Kimberly, Miller, Richard K, Guzick, David S. A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: A pilot study. Fertility and sterility, vol.82, no.2, 421-429.
Nestler, John E., Jakubowicz, Daniela J., Evans, William S., Pasquali, Renato. Effects of Metformin on Spontaneous and Clomiphene-Induced Ovulation in the Polycystic Ovary Syndrome. The New England journal of medicine, vol.338, no.26, 1876-1880.
Moran, L. J., Noakes, M., Clifton, P. M., Tomlinson, L., Norman, R. J.. Dietary Composition in Restoring Reproductive and Metabolic Physiology in Overweight Women with Polycystic Ovary Syndrome. The Journal of clinical endocrinology & metabolism, vol.88, no.2, 812-819.
Stamets, Kelly, Taylor, Denise S, Kunselman, Allen, Demers, Laurence M, Pelkman, Christine L, Legro, Richard S. A randomized trial of the effects of two types of short-term hypocaloric diets on weight loss in women with polycystic ovary syndrome. Fertility and sterility, vol.81, no.3, 630-637.
Mansfield, Rebecca, Galea, Ray, Brincat, Mark, Hole, David, Mason, Helen. Metformin has direct effects on human ovarian steroidogenesis. Fertility and sterility, vol.79, no.4, 956-962.
Attia, George R, Rainey, William E, Carr, Bruce R. Metformin directly inhibits androgen production in human thecal cells. Fertility and sterility, vol.76, no.3, 517-524.
Cochrane Database Syst Rev Lord JM CD003053 3 2003
10.1210/jc.80.7.2057
Glueck, C.J., Goldenberg, N., Pranikoff, J., Loftspring, M., Sieve, L., Wang, P.. Height, weight, and motor–social development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy. Human reproduction, vol.19, no.6, 1323-1330.
Glueck, C.J, Wang, Ping, Kobayashi, Suichi, Phillips, Harvey, Sieve-Smith, Luann. Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome. Fertility and sterility, vol.77, no.3, 520-525.
Glueck, Charles J., Wang, Ping, Goldenberg, Naila, Sieve-Smith, Luann. Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin. Human reproduction, vol.17, no.11, 2858-2864.
Glueck, C.J, Phillips, Harvey, Cameron, Dan, Sieve-Smith, Luann, Wang, Ping. Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study. Fertility and sterility, vol.75, no.1, 46-52.
10.1016/S1071-5576(02)00149-1
10.1210/jc.81.9.3299
Ghazeeri, Ghina, Kutteh, William H, Bryer-Ash, Michael, Haas, Derek, Ke, Raymond W. Effect of rosiglitazone on spontaneous and clomiphene citrate–induced ovulation in women with polycystic ovary syndrome. Fertility and sterility, vol.79, no.3, 562-566.
Belli, Susana H, Graffigna, Mabel N, Oneto, Adriana, Otero, Patricia, Schurman, Leon, Levalle, Oscar A. Effect of rosiglitazone on insulin resistance, growth factors, and reproductive disturbances in women with polycystic ovary syndrome. Fertility and sterility, vol.81, no.3, 624-629.
Romualdi, D., Guido, M., Ciampelli, M., Giuliani, M., Leoni, F., Perri, C., Lanzone, A.. Selective effects of pioglitazone on insulin and androgen abnormalities in normo‐ and hyperinsulinaemic obese patients with polycystic ovary syndrome. Human reproduction, vol.18, no.6, 1210-1218.
Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin. The New England journal of medicine, vol.346, no.6, 393-403.
Tuomilehto, Jaakko, Lindström, Jaana, Eriksson, Johan G., Valle, Timo T., Hämäläinen, Helena, Ilanne-Parikka, Pirjo, Keinänen-Kiukaanniemi, Sirkka, Laakso, Mauri, Louheranta, Anne, Rastas, Merja, Salminen, Virpi, Aunola, Sirkka, Cepaitis, Zygimantas, Moltchanov, Vladislav, Hakumäki, Martti, Mannelin, Marjo, Martikkala, Vesa, Sundvall, Jouko, Uusitupa, Matti. Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance. The New England journal of medicine, vol.344, no.18, 1343-1350.
Screening for Type 2 Diabetes. Diabetes care, vol.27, no.suppl1, s11-s14.
Dunaif, Andrea, Sorbara, Lynn, Delson, Roberta, Green, Georgette. Ethnicity and Polycystic Ovary Syndrome are Associated With Independent and Additive Decreases in Insulin Action in Caribbean-Hispanic Women. Diabetes, vol.42, no.10, 1462-1468.
10.1210/jc.83.8.2694
Legro, Richard S., Castracane, V. Daniel, Kauffman, Robert P.. Detecting Insulin Resistance in Polycystic Ovary Syndrome: Purposes and Pitfalls. Obstetrical & gynecological survey, vol.59, no.2, 141-154.
Diamanti-Kandarakis, Evanthia, Kouli, Chryssa, Alexandraki, Krystallenia, Spina, Giovanna. Failure of Mathematical Indices to Accurately Assess Insulin Resistance in Lean, Overweight, or Obese Women with Polycystic Ovary Syndrome. The Journal of clinical endocrinology & metabolism, vol.89, no.3, 1273-1276.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.